Presentations
Satellite Meeting (Sunday/22 May)
- Welcome & Opening Remarks – Horst Spielmann, Freie Universität Berlin, DE
- EU-COLIPA SEURAT-1 Project: Towards the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing – Michael Schwarz, University of Tübingen, DE
- The "Human Toxicology Project" – Andrew Rowan, Humane Society International, US
- Tox21 and Disease Pathway Interrogation – Bob Kavlock, Environmental Protection Agency, US
- Human Skin Disease Models – Monika Schäfer-Korting, Freie Universität Berlin, DE
- BMBF Project "The Virtual Liver" – Jan Hangstler, IfADo, DE
- BMBF Go-Bio Project "From Single Tissue Culture to Multi-Organ Chips" – Uwe Marx, Berlin TissUse & TU Berlin, DE
- The IMI eTox Project: Efforts to Develop In Silico Tools to Predict In Vivo Toxicity – Thomas Steger-Hartmann, Bayer Schering, DE
Workshop - Day 1 (Monday/23 May)
Progress Reports from FP6/7 Projects
- ACuteTox – Annette Kopp-Schneider, DKFZ, DE
- NanoTest – Maria Dusinska, NILU, NO
- OpenTox – Barry Hardy, Douglas Connect, CH
- ESNATS – Marcel Leist, Universität Konstanz, DE
- PREDICT-IV – Christof Burek, Universität Würzburg, DE
- START-UP – Peter Maier, University of Zürich, CH
Case Study 1: Reproductive Toxicity
- Genetic Causes of Congenital Cardiac Defects – Silke Sperling, Charité & MDC, DE
- ToxCast & Tox21 Projects – Robert Kavlock, Environmental Protection Agency, US
- ReProTect – Michael Schwarz, Universität Tübingen, DE
- Protein Biomrkers for Embryotoxicity – André Schrattenholz, Proteosys, DE
- ES Cells and Molecular Endpoints – Aldert Piersma, RIVM, NL
- CHEMSCREEN – Bart van der Burg, BDS, NL
- Virtual Embryo – Tom Knudsen, Environmental Protection Agency, US
Case Study 2: Skin Sensitisation
- Genomic Allergen Rapid Detection Test – Malin Lindstedt, Lund University, SE
- Gene Expression in Dendritic Cells: From Statistical Modelling to Pathway Discovery – Jef Hooyberghs, VITO, BE
- Modelling the Human Adverse Response – Gavin Maxwell, Unilever, UK
- OECD Adverse Outcome Pathway Approach – Steven Enoch, Liverpool John Moors University, UK
Workshop - Day 2 (Tuesday/24 May)
- Transcriptional Response to Chemicals – Morgane Thomas-Chollier, MPI Berlin, DE
- METI-NEDO High Throughput Assay Systems – Noriho Tanaka, Hatano Research Institute, JP
- Progress Toward Toxicity Testing in the 21st Century – Harvey Clewell, Hamner Institutes, US
- Collaboration Between the JRC and Tox21 – Maurice Whelan, European Commission, IT
- Safety Assessment at Unilever Applying the Tox21 Approach – Julia Fentem, Unilever, UK
- Coordination Actions and Research Policy – Jürgen Büsing, European Commission, BE
Breakout Groups - Roadmap to Innovative Toxicity Testing
- BOG1: Cross-Cutting Issues
- BOG2: Reproductive Toxicity
- BOG3: Sensitisation
